ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,523,809 | -64.0% | 329,601 | -42.6% | 0.02% | -61.9% |
| Q2 2023 | $4,236,597 | -0.3% | 573,915 | +18.9% | 0.04% | -4.5% |
| Q1 2023 | $4,249,473 | -26.3% | 482,633 | -6.0% | 0.04% | -30.2% |
| Q4 2022 | $5,767,384 | -9.3% | 513,564 | -2.7% | 0.06% | -12.5% |
| Q3 2022 | $6,361,691 | +39.7% | 527,660 | +48.9% | 0.07% | +41.2% |
| Q2 2022 | $4,554,309 | +6.5% | 354,476 | -0.6% | 0.05% | +21.4% |
| Q1 2022 | $4,276,264 | +50.5% | 356,626 | +97.1% | 0.04% | +50.0% |
| Q4 2021 | $2,840,479 | – | 180,955 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |